MiR-30a increases cisplatin sensitivity of gastric cancer cells through suppressing epithelial-to-mesenchymal transition (EMT).

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 27212164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer

  2016cited by this paper
• MiR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1.

  2016cited by this paper
• MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy.

  2016cited by this paper
• MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.

  2015cited by this paper
• Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric Cancer

  2015cited by this paper
• miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma

  2015cited by this paper
• miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach

  2015cited by this paper
• DNA damage regulates ARID1A stability via SCF ubiquitin ligase in gastric cancer cells.

  2015cited by this paper
• High glucose promotes gastric cancer chemoresistance in vivo and in vitro

  2015cited by this paper
• MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2

  2015cited by this paper
• The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells

  2015cited by this paper
• MiR-126 inhibits the invasion of gastric cancer cell in part by targeting Crk.

  2014cited by this paper
• Effects of microRNA‐30a on migration, invasion and prognosis of hepatocellular carcinoma

  2014cited by this paper
• RUNX3 regulates vimentin expression via miR-30a during epithelial–mesenchymal transition in gastric cancer cells

  2014cited by this paper
• MicroRNAs and drug resistance in prostate cancers.

  2014cited by this paper
• Oncologic outcomes of laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective cohort study from China

  2014cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Mechanisms of Resistance to Cabazitaxel

  2014cited by this paper
• Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.

  2014cited by this paper
• Down-regulation of microRNA-205 promotes gastric cancer cell proliferation.

  2014cited by this paper
• Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy.

  2014cited by this paper
• Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients.

  2014cited by this paper
• Gene expression profiling of gastric cancer.

  2014cited by this paper
• miR-30 a Negatively Regulates TGF-b 1 e Induced Epithelial-Mesenchymal Transition and Peritoneal Fibrosis by Targeting Snai 1

  2013cited by this paper
• MicroRNA‐106a induces multidrug resistance in gastric cancer by targeting RUNX3

  2013cited by this paper
• MicroRNA‐30a inhibits epithelial‐to‐mesenchymal transition by targeting Snai1 and is downregulated in non‐small cell lung cancer

  2012cited by this paper
• MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer

  2012cited by this paper
• Gene Expression Profiling of Gastric Cancer

  2011cited by this paper
• New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives.

  2010cited by this paper
• Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53‐Mediated Apoptosis and Acquiring a Stem‐Like Phenotype in Ovarian Cancer Cells

  2009cited by this paper
• Survival prediction of gastric cancer by a seven-microRNA signature

  2009cited by this paper
• miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

  2008cited by this paper
• Cancer statistics

  1989cited by this paper

• Comprehensive in silico and in vitro studies reveal the miR-30a/CALU axis as a potential therapeutic target in colorectal cancer

  2026cites this paper
• Gastric Cancer Epithelial-Mesenchymal Transition-The Role of Micro-RNA

  2026cites this paper
• Upregulation of CircXPO1 Promotes the Progression of Gastric Cancer and May Serve as a Potential Auxiliary Biomarker for Its Diagnosis

  2025cites this paper
• IGFBP1 is One of 10 Metabolic Factors Predicting Recurrence Free Survival in Gastric Cancer and Promotes Cancer Progression via ZFX-IGFBP1 Axis

  2025cites this paper
• Ginsenoside CK inhibits EMT and overcomes oxaliplatin resistance in gastric cancer by targeting the PI3K/Akt pathway.

  2025cites this paper
• Autophagy Inhibition and Sensitization to Cisplatin in Esophageal Cancer Stem-Like Cells via All-trans Retinoic Acid-induced miR-30a.

  2024cites this paper
• miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers.

  2023cites this paper
• Mechanism of cisplatin resistance in gastric cancer and associated microRNAs

  2023cites this paper
• MiRNAs and lncRNAs impact on multidrug resistance of gastric cancer.

  2022cites this paper
• In silico Identification of miRNA as possible therapeutic targets for Micro Invasive Bladder Cancer (MIBC) treatment

  2022cites this paper
• A novel 4 miRNA signature from salivary exosomes regulates multiple signalling pathways and predicts tumour progression in oral squamous cell carcinoma

  2022cites this paper
• CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer

  2022cites this paper
• MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?

  2022cites this paper
• Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer

  2021cites this paper
• MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells

  2021influential citation
• MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy

  2021cites this paper
• LncRNAs and miRNAs participate in determination of response of cancer cells to cisplatin.

  2021cites this paper
• Unravelling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma.

  2021cites this paper
• MicroRNAs are involved in the development and progression of gastric cancer

  2020cites this paper
• The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma

  2020cites this paper
• Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance

  2020cites this paper
• Non-coding RNAs underlying chemoresistance in gastric cancer

  2020influential citation
• The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma

  2020cites this paper
• Molecular Signaling Pathways Involved in Gastric Cancer Chemoresistance

  2020cites this paper
• Non-coding RNAs underlying chemoresistance in gastric cancer

  2020cites this paper
• microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2

  2020cites this paper
• Theranostics Approaches to Gastric and Colon Cancer

  2020cites this paper
• lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p

  2020cites this paper
• MiR-148a-3p suppresses the progression of gastric cancer cells through targeting ATP6AP2

  2020cites this paper
• Non-coding RNAs in regulating gastric cancer metastasis.

  2019cites this paper
• MicroRNA-30a-3p regulates epithelial-mesenchymal transition to affect embryo implantation by targeting Snai2†.

  2019cites this paper
• Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review)

  2019cites this paper
• MicroRNA-613 induces the sensitivity of gastric cancer cells to cisplatin through targeting SOX9 expression.

  2019cites this paper
• MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.

  2019cites this paper
• Vimentin expression is retained in erythroid cells differentiated from human iPSC and ESC and indicates dysregulation in these cells early in differentiation

  2019cites this paper
• Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells

  2019cites this paper
• MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition via TGFβ1/Smad2 signaling pathway in human bladder cancer

  2019cites this paper
• LINC00994 promoted invasion and proliferation of gastric cancer cell via regulating miR-765-3p.

  2019cites this paper
• Non-coding RNA in drug resistance of gastric cancer

  2019cites this paper
• Research Progress in microRNA-Based Therapy for Gastric Cancer

  2019cites this paper
• OTT_A_221354 11393..11411

  2019influential citation
• Bioinformatic Analysis of GLI1 and Related Signaling Pathways in Chemosensitivity of Gastric Cancer

  2018cites this paper
• MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition

  2018cites this paper
• MiR‐30‐5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β‐catenin signaling axis

  2018cites this paper
• MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

  2018influential citation
• GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer

  2018cites this paper
• miR-644a Inhibits Cellular Proliferation and Invasion via Suppression of CtBP1 in Gastric Cancer Cells

  2018cites this paper
• MiR‐30a‐5p ameliorates spinal cord injury‐induced inflammatory responses and oxidative stress by targeting Neurod 1 through MAPK/ERK signalling

  2018cites this paper
• miR-30a regulates the proliferation and invasion of breast cancer cells by targeting Snail.

  2018cites this paper
• MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells

  2018cites this paper
• miR-30a suppresses lung cancer progression by targeting SIRT1

  2017cites this paper
• A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells

  2017cites this paper
• HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition.

  2017cites this paper
• MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.

  2017cites this paper
• DNMT3A-mediated down-regulation of microRNA-105 promotes gastric cancer cell proliferation.

  2017cites this paper
• The Versatile Role of microRNA-30a in Human Cancer

  2017cites this paper
• TMED2 promotes epithelial ovarian cancer growth

  2017cites this paper
• miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression

  2017cites this paper
• TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells.

  2017cites this paper
• In vitro Evidence on Associations between MicroRNAs and Response to Therapy in Gastric Cancer: Report from the Encyclopedia Amlashica Systematic Reviews

  2017cites this paper
• EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells

  2017cites this paper
• MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells

  2017cites this paper
• HOXA 13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition

  2017cites this paper
• Expression and significances of MiRNA Let-7 and HMGA2 in laryngeal carcinoma.

  2016cites this paper
• Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs

  2016cites this paper
• Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b

  2016cites this paper
• miR-494 inhibits invasion and proliferation of gastric cancer by targeting IGF-1R.

  2016cites this paper
• MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in human non-small cell lung cancer.

  2016cites this paper
• GAS5 is downregulated in gastric cancer cells by promoter hypermethylation and regulates adriamycin sensitivity.

  2016cites this paper
• miR-760 mediates chemoresistance through inhibition of epithelial mesenchymal transition in breast cancer cells.

  2016cites this paper
• Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.

  2016cites this paper